NeoThelium™ products provide protective coverage from the surrounding environment for acute and chronic wounds. All NeoThelium™ products retain the spongy (intermediate) layer.
The spongy (intermediate) layer is a rich source of bioactive molecules, comprising essential growth factors and matrix proteins such as hyaluronic acid (HA), transforming growth factor beta 1 (TGF-β1), hepatocyte growth factor (HGF), and interleukin-1 receptor antagonist (IL-1Ra). Note: These components are naturally found in the spongy layer; their specific activity in NeoThelium™ products has not been evaluated.
NeoThelium™ FT
A full-thickness Amnion/Spongy/Chorion allograft designed for single-use as a wound covering. Its two-layer composition offers a straightforward, natural option for a variety of clinical applications. Each layer is preserved to maintain the inherent properties of the tissue, delivering a streamlined solution for coverage needs.
NeoThelium™ 4L
A full-thickness Amnion/Spongy/Chorion/Chorion/Spongy/Amnion configuration, creating a four-layer structure for single-use wound covering applications. The unique layering provides a robust, naturally derived option for clinicians seeking a multi-layer format, while maintaining the characteristics of the source tissue.
NeoThelium™ 4L+
A full-thickness Chorion/Spongy/Amnion/Amnion/Spongy/Chorion allograft designed for single-use as a wound covering. Its distinctive four-layer arrangement offers an alternative structural configuration within the NeoThelium™ portfolio, providing clinicians with another naturally derived option while retaining the integrity of the original tissue composition.
NeoThelium™ is an amniotic membrane allograft derived from a prescreened mother with a planned delivery. NeoThelium™ is manufactured in compliance with FDA regulations. The membrane is minimally processed to preserve the native structure of the tissue, dehydrated, and terminally sterilized. NeoThelium™ is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
Phone: 844-464-8252 Email: info@nsmbiologics.com
Copyright © 2025 NSM Biologics - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.